200
Participants
Start Date
May 4, 2021
Primary Completion Date
May 31, 2025
Study Completion Date
May 31, 2029
Tendyne™ Mitral Valve System
Transcatheter mitral valve implantation (TMVI) using the Tendyne™ Mitral Valve System , in which a bioprosthetic valve is implanted within the native mitral valve.
Kepler University Hospital, Linz
UZ Gasthuisberg, Leuven
University Hospital Olomouc, Olomouc
IKEM Prague, Prague
Hospital AGEL Trinec-Podlesi, Třinec
Bordeaux University Hospital, Bordeaux
CHRU de Lille, Lille
Lyon University Hospital, Lyon
Rennes University Hospital, Rennes
Clinique Pasteur, Toulouse
Heart and Diabetes Center NRW, Bad Oeynhausen
German Heart Center Berlin, Berlin
University Hospital Bonn, Bonn
Universitätsclinic Cologne, Cologne
University Hospital Frankfurt, Frankfurt
University Heart Center Hamburg, Hamburg
Universitätsklinikum Schleswig-Holstein Campus Kiel, Kiel
Leipzig Heart Center, Leipzig
University Medical Center Mainz, Mainz
German Heart Center Munich, Munich
Ludwig-Maximilians-Universität (LMU) München / Campus Großhadern, München
Robert-Bosch Krankenhaus, Stuttgart
Shaare Zedek Jerusalem, Jerusalem
Sheba Medical Centre, Tel Aviv
Lancisi Cardiovascular Center - Politechnic University of Marcher, Ancona
AOU Civili Brescia, Brescia
Azienda Ospedaliero Universitaria Pisana, Pisa
MUMC+, Maastricht
Oslo University Hospital, Oslo
King Fahad Armed Forces, Jeddah
King Fahad Medical City, Riyadh
King Faisal Specialist Hospital & Research Center, Riyadh
Clinico San Carlos, Madrid
University Hospital Basel, Clinic for Cardiac Surgery, Basel
Insel Bern, Bern
Royal Brompton Hospital, London
Lead Sponsor
Abbott Medical Devices
INDUSTRY